Seeking Alpha

funfun

funfun
Send Message
View as an RSS Feed
View funfun's Comments BY TICKER:
Latest  |  Highest rated
  • Dupont Issues Mixed Earnings Results But Is Worthy Of A Position In Any Dividend Portfolio [View article]
    Fan, no doubt about it. DuPont Management has been coasting on cleverly cobbled PR campaigns and IMAGE-fabrication for the entire 21st century, pretending at the moment to be some sort of superlative "science and technology" boutique.

    Commercial reality: What high-profit blockbusting products or technologies has the once world renown, but now shrunken and demoralised research laboratories of DuPont come up with in the past five years, other than an insecticide with a silly name which defies spelling, pronunciation, and memory--RYNAXPYR? Costly DuPont corn cob "gasoline" (bad mileage ethanol) hardly makes the cut.

    …funfun..
    Apr 18 10:20 AM | Likes Like |Link to Comment
  • General Motors - The Story Just Keeps Getting Worse [View article]
    Many investors will recall the explosive news disclosed by the New York Times on March 13, 2014: "303 Deaths Seen in GM Cars With Failed Airbags".

    A careful review of federal crash data showed that 303 people died after the air bags failed to deploy on two of the GM models that were recalled last month.

    It is highly likely that some of these crashes involved the faulty ignition switch, and, in our opinion, the scope of the switch issue has been vastly understated and soft-pedaled by an evasive and secretive GM Management, hiding behind a cynical PR trick of Blame-the-Victim.

    The review of the air bag failures from 2003 to 2012, was performed by the Friedman Research Corporation, which specialises in car safety research.

    Merely the perspective of one individual investor with both short and long positions in GM. …funfun..
    Apr 18 10:08 AM | Likes Like |Link to Comment
  • NY, Beijing auto shows set to kick off [View news story]
    General Motors cars should go over well in Beijing, where safety and human life is a mere inconvenience. It's the Peoples Republic of China, where they feed babies poisoned milk, and choke on lethal smog, and dispatch hundreds of newborn infant girls to the drowning waters of rice paddies every year. …funfun..
    Apr 18 09:49 AM | 1 Like Like |Link to Comment
  • GM yet to test faulty ignition switches for knee-bump problem [View news story]
    Meanwhile in the long-drawn out recall process, the CoBALK driver and his or her passengers will be playing Russian Roulette on the Road.

    Don't hit any potholes, and, obese drivers, keep your fat knees away.

    More SHAM SAFETY brought to you by GM Management and their esteemed cost accountants.

    …funfun..
    Apr 18 09:41 AM | Likes Like |Link to Comment
  • Dupont Issues Mixed Earnings Results But Is Worthy Of A Position In Any Dividend Portfolio [View article]
    The pronounced weakness in the DuPont AG segment suggests DuPont AG may not be the agricultural powerhouse envisioned by DuPont Senior Management. Sales in Q1 for DuPont AG tumbled, down 6%, 7% by volume. Operating earnings were off 5%. Seed sales took a dive, down a whopping 9%.

    Overall DuPont AG had a sick quarterly performance, which DuPont's accountability-evasive Management was quick to blame on the weather. Trouble is, Monsanto reported robust gains in sales and income in Monsanto's latest quarter, and presumably Monsanto customers experienced the same winter storms in North America.

    Competition in the global business of agriculture is intensifying with powerful players such as Monsanto, Syngenta, BASF, Bayer, Dow AgroSciences. Unfortunately for the dreams of Ms. Kullman, DuPont Chieftess who wants to make a chemicals-free DuPont an ag juggernaut, DuPont has been left playing second fiddle to Monsanto in seed biotechnology and production, and third fiddle to Syngenta and Bayer in crop protection and ag chemicals. (Imprelis, Tell Us!)

    Merely the viewpoint of one individual investor, with long positions in MON, SYT, DOW, and long and short positions in DD…funfun..
    Apr 18 09:35 AM | Likes Like |Link to Comment
  • General Motors - The Story Just Keeps Getting Worse [View article]
    General Motors Management in Detroit and their PR cosmeticians like to publicise the good results of crash tests on their cars. Presumably that is to provide comfort and assurance to those purchasing their GM cars containing a potentially lethally defective part within, which might lead to a severe crash. ...funfun..
    Apr 18 09:05 AM | Likes Like |Link to Comment
  • Dow Chemicals: Should You Buy It? [View article]
    The sickly performance delivered by DuPont Management for the first quarter, 2014, argues for the superiority of Dow Chemical Company in the intermediate future for equity investment. By a number of financial metrics, Dow is twice the size of the much shrunken DuPont Company.

    DuPont's overall sales tumbled, down 3% and earnings were flat in Q1. For years, DuPont Chieftess Ellen J. Kulman has been hyping her DuPont AG business segment as her crown jewel, the wave of the future for this shrinking conglomerate based in the dwarf state of Delaware. But sales for DuPont AG in Q1 took a dive, down 6%, and down 7% on volume. Operating earnings of DuPont AG were off an embarrassing 5%, with sales of seeds tumbling, down 9%.

    It would appear in coming quarters, DuPont AG will not be the glorious global powerhouse in agriculture envisioned by Ms. Kullman and her tired team. She will be playing second fiddle to Monsanto in seed biotechnology, and third fiddle to Syngenta and Bayer in crop protection and ag chemicals.

    Dow with its own robustly growing Dow AgroSciences is attractively priced in the high forties in our opinion.

    ...funfun..
    Apr 18 08:58 AM | 1 Like Like |Link to Comment
  • General Motors - The Story Just Keeps Getting Worse [View article]
    Mr. Blair puts forth a cogent case that matters will be worsening at General Motors, given the embedded damaging culture. The company is only in the second or third inning of what will be disastrous discovery from ongoing federal and state investigations, as well as intensive discovery in litigation, again federal and state. As we write, a truculent and evasive GM Management is earning GM a $7000 daily fine for refusing to turn over a third of the documents, and answer questions demanded by NHTSA.

    The same inbred and inept and integrity-depleted Management remains glued in place in the organisational structure. It will take a long time before favourable change can be hammered out.

    In summary, ENRON ETHICS destroys, does not build shareholder value.

    Merely the perspective of one individual retail investor, with both short and long positions in GM...funfun..
    Apr 18 08:39 AM | Likes Like |Link to Comment
  • E. I. du Pont de Nemours' CEO Discusses Q1 2014 Results - Earnings Call Transcript [View article]
    DuPont Chieftess Ellen Kullman appeared to bristle when JP Morgan's Jeff Zekauskas refers to "chemical companies" during an earlier quarterly Conference Call, April 19, 2012:

    "Well, actually, I'd like to start first to say we're not a chemical company,.."

    But the fact is well over half of DuPont's sales in Q1, 2012 came from industrial chemicals and chemical-based specialty and commodity materials.

    ...funfun..
    Apr 17 09:05 PM | Likes Like |Link to Comment
  • E. I. du Pont de Nemours  (DuPont) misses by $0.01, misses on revenue [View news story]
    While Ms. Kullman and her Vice Presidents and CFO splattered their conference call with the word "growth" ubiquitously, there was certainly no growth in the touted DuPont AG segment. Seed sales, for example, took a dive, down 9% for the quarter, and may be flat for the 1st half, 2014.

    Bottom-line, there is more and more evidence that DuPont AG is not going to be the powerhouse, Ms. Kullman has envisioned. Unfortunately for DD shareholders, DuPont is an also-ran to Monsanto and Syngenta. …funfun..
    Apr 17 05:04 PM | Likes Like |Link to Comment
  • E. I. du Pont de Nemours' CEO Discusses Q1 2014 Results - Earnings Call Transcript [View article]
    Given the shortfall in DuPont AG in Q1, Don Carson, Susquehanna Financial, asks how will DuPont maintain its full year EPS guidance. The first words out of Ms. Kullman's mouth is chemicals. But she's dumping chemicals via a spin-off in a year.

    Ironically, DuPont is the world leader and largest producer in TIO2, and a leader in Teflon and refrigerants. She's trading chemicals to play second fiddle to Monsanto in seed biotechnology and third fiddle to Syngenta and Bayer in crop protection and ag chemicals.

    Query, how does Ms. Kullman plan to make up the 20% of her total yearly revenues of $37 billion, or circa $7 billion representing chemicals? That's a whale of a lot of seeds and crop protection and sundry materials, and her seed sales took a dive, down 9% in Q1.

    …funfun..
    Apr 17 04:24 PM | 1 Like Like |Link to Comment
  • Judge rules GM doesn't have to give parking order [View news story]
    In the meantime, millions of Chevy CoBALK drivers do not know whether or not a permanent passenger is riding with them, namely the Grim Reaper. …funfun..
    Apr 17 01:50 PM | 2 Likes Like |Link to Comment
  • Winter storms weigh on DuPont's mixed Q1 results [View news story]
    In view of the pervasive weakness in the first quarter, Ms. Kullman's reaffirmed projection of full year EPS at $4.20 to $4.45 now appears Pollyannaish.

    …funfun..
    Apr 17 09:20 AM | Likes Like |Link to Comment
  • Winter storms weigh on DuPont's mixed Q1 results [View news story]
    Strangely, the very same winter storms also hit Monsanto's customers, but superior-managed Monsanto showed strong gains in revenues and earnings in its last quarterly report.

    DuPont's accountability-evasive executives are never responsible for their sick performances. Investors beware and be wary, where public relations and cosmetics trump sales and profits.

    …funfun..
    Apr 17 09:03 AM | Likes Like |Link to Comment
  • E. I. du Pont de Nemours  (DuPont) misses by $0.01, misses on revenue [View news story]
    For years, Ellen J. Kullman, DuPont Chieftess, has been touting her DuPont AG segment as the crown jewel of this shrinking Delaware-based conglomerate. In Q1 2014, DuPont AG looked especially weak, with sales tumbling down 6%, and operating earnings, down 5%.

    The stark commercial reality, which few discuss, is DuPont is a pronounced laggard to Monsanto in seed biotechnology and production, and to Syngenta and Bayer in crop protection and ag chemicals. …funfun..
    Apr 17 07:31 AM | Likes Like |Link to Comment
COMMENTS STATS
875 Comments
598 Likes